AIPHIA Capital Partners is a venture capital firm providing early stage capital and expertise to innovative entrepreneurs building disruptive life sciences companies.

AIPHIA Capital Partners has a team of experienced professionals to source, analyze and engage in investments in companies with novel therapeutic products and technologies.

Our investment strategy considers opportunities all over the world, with emphasis on Switzerland, Germany and Austria.